Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm

Alzheimer's disease (AD) represents a particular therapeutic challenge because its aetiology is very complex, with dynamic progression from preclinical to clinical stages. Several potential therapeutic targets and strategies were tested for AD, in over 2000 clinical trials, but no disease-modif...

Full description

Saved in:
Bibliographic Details
Main Authors: Wioleta Grabowska-Pyrzewicz, Andrew Want, Jerzy Leszek, Urszula Wojda
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
R
Online Access:https://doaj.org/article/a829b7ada1024b9f994e0a86a7acb583
Tags: Add Tag
No Tags, Be the first to tag this record!